Dr. Mavis studies a variety of conditions related to organ transplants, primarily looking at how to improve treatment and outcomes for patients with liver and intestinal diseases. Her research includes examining the management of rare pediatric liver diseases like biliary atresia and testing the safety of live vaccines for solid organ transplant recipients. She also investigates how maternal smoking affects children's metabolic health, which can influence their need for liver transplants later in life. By focusing on patient education and the standardization of care practices, Dr. Mavis aims to make a significant impact on the lives of transplant patients and their families.
Key findings
In her study on pediatric liver diseases, IBAT inhibitors showed success in managing symptoms, particularly itching, indicating new avenues for treatment.
Research on intestinal transplants revealed an increase in procedures from 398 in the first decade to 1,235 in the last, highlighting a growing recognition of the need for such surgeries.
Among 275 pediatric transplant recipients studied, a tenfold increase in Epstein-Barr virus (EBV) levels significantly doubled the risk of developing post-transplant lymphoproliferative disorder.
The one-year survival rate for children undergoing liver transplants for hepatoblastoma improved from 84.6% to 89.1%, showcasing enhanced treatment success over time.
In her mHealth study, 88% of pediatric transplant families reported feeling more knowledgeable and confident in managing care, linking technology with better support.
Frequently asked questions
Does Dr. Mavis study liver diseases in children?
Yes, Dr. Mavis focuses on rare pediatric liver diseases and examines new treatment options to improve symptoms and care for affected children.
What are Dr. Mavis's contributions to organ transplant research?
Dr. Mavis's research examines immunological assessments, treatment strategies, and patient education related to organ transplants, aiming to improve patient outcomes.
Is Dr. Mavis's work relevant to adult transplant patients?
Yes, her research includes important findings for adult patients needing intestinal transplants and highlights the need for improved long-term care in this population.
What findings does Dr. Mavis have about vaccinations in transplant recipients?
Her research indicates that live vaccines for children who received solid organ transplants can be safe and effective, challenging previous restrictions.
How does smoking during pregnancy affect children according to Dr. Mavis's research?
Her study found that children of mothers who smoked have lower activity of a metabolism-related gene, which is linked to higher health risks later in life.
Publications in plain English
A survey of national practice patterns of HCC surveillance for patients with Fontan-associated liver disease: A call to action.
2025
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Kappus MR, Hughes D, Ganger DR, Kim Y, Bashir M +24 more
Recent advances in the management of pediatric cholestatic liver diseases.
2025
Journal of pediatric gastroenterology and nutrition
Mysore KR, Cheng K, Suri LA, Fawaz R, Mavis AM +3 more
Plain English This paper looks at rare liver diseases in children, focusing on conditions like biliary atresia and Alagille syndrome, which can cause liver problems and often lead to the need for a transplant. The research highlights new treatments that can help manage symptoms, such as itching, especially with drugs called IBAT inhibitors, which showed some success in trials. However, there is still a crucial need for effective treatments that can actually slow down the progression of these liver diseases to improve kids' lives.
Trends in the Perioperative Practices for Immunological Assessment and Immunosuppression Strategies for Patients Undergoing Intestinal Transplantation at American Transplant Centers.
2025
Transplantation proceedings
Abusuliman M, Jafri SM, Summers BB, Beduschi T, Boike J +15 more
Plain English This study looked at how major transplant centers in the U.S. assess and manage immune system issues for patients undergoing intestinal transplants. Researchers surveyed ten centers, finding that while all used similar processes for testing before and after transplants, there was a wide range in how they handled specific treatments for immune responses, such as desensitization and managing rejection. Standardizing these practices is essential because it could lead to better health outcomes for patients receiving these complex surgeries.
Incidence and Outcomes of Simultaneous Thoracoabdominal Triple Organ Transplantation in the United States.
2024
Transplantation proceedings
Adjei MA, Wisel SA, Steggerda JA, Mirocha J, Mavis A +2 more
Plain English This study looked at how patients do after receiving triple organ transplants that combine heart, lungs, kidneys, and liver. It found that patients who received a heart-lung-kidney transplant had a 10-year survival rate of 45%, while those receiving a heart-liver-kidney transplant had a 49% survival rate, which is similar to those who received just two organs. This is important because it shows that adding a third organ in these transplants does not negatively impact survival, making it a viable option for patients who need more than one organ.
Who this helps: Patients needing multiple organ transplants.
Contemporary trends in choledochal cyst excision: An analysis of the pediatric national surgical quality improvement program.
2024
World journal of surgery
Howell TC, Beckhorn CB, Antiel RM, Fitzgerald TN, Rice HE +3 more
Plain English This study looked at the surgery to remove choledochal cysts, which are uncommon birth defects affecting the bile ducts in children. Researchers analyzed data from 407 children who had this surgery between 2015 and 2020, finding that those who had a specific type of reconstruction (Roux-en-Y hepaticojejunostomy) had a lower chance of needing to be readmitted to the hospital afterward (4% compared to 10.5% for another method). These findings are important because they help doctors make better decisions about surgical techniques that lead to fewer complications for young patients.
Who this helps: This helps patients and their families by improving surgical outcomes for children with choledochal cysts.
Evolution of intestinal and multivisceral transplantation: A thirty-year United States perspective.
2024
Intestinal Failure (New York, N.Y.)
Samoylova ML, Kesseli SJ, Park C, Yerxa J, Horslen S +8 more
Plain English This study looked at how intestinal transplants in the U.S. have evolved over the past 30 years, focusing on changes in the number of surgeries and survival rates for patients. Overall, there were 3,035 transplants from 1990 to 2020, with the number increasing significantly over time: from 398 in the first decade to 1,235 in the last. It found that while more adults are receiving these transplants (from 35% to 59%), survival rates have improved for children, but have not changed much for adults, showing a need for better long-term care for adult patients.
Who this helps: This research helps patients, especially adults needing intestinal transplants, and their doctors seeking to improve outcomes.
Pneumothoraxes after CT-guided percutaneous transthoracic needle aspiration biopsy of the lung: A single-center experience with 3426 patients.
2023
Tuberkuloz ve toraks
Polat G, Özdemir Ö, Serçe Unat D, Karadeniz G, Ayrancı A +4 more
Plain English This study looked at 3,426 patients who underwent a lung biopsy and found that 314 of them (about 9%) developed a collapsed lung, known as pneumothorax. Out of these, 117 patients (37%) needed a chest tube to treat it, with the main risk factor being the depth of the lung lesion; if it was deeper than 24 millimeters, the likelihood of needing a chest tube increased nearly five times. This information is important as it helps doctors understand which patients might have a higher risk of complications and need more careful monitoring after the procedure.
Who this helps: This helps patients undergoing lung biopsies and their doctors by identifying risk factors for complications.
Development of a national Zoom-based lectureship for pediatric transplant hepatology trainees.
2023
Pediatric transplantation
Banc-Husu AM, Bonn J, Mavis AM, Feldman AG
Plain English A group of educators created a Zoom lecture series to improve training for pediatric liver transplant specialists in the U.S. and Canada. Out of 16 participants, 88% felt that the series boosted their knowledge and confidence about managing children's liver diseases, and 81% appreciated the networking opportunities it provided. This program is important because it fills a gap in education and helps train doctors who care for children with serious liver conditions.
AHRR Hypomethylation mediates the association between maternal smoking and metabolic profiles in children.
2023
Hepatology communications
Vidal AC, Chandramouli SA, Marchesoni J, Brown N, Liu Y +10 more
Plain English This study looked at how smoking during pregnancy affects children's health, specifically focusing on a gene related to metabolism. Researchers found that children of mothers who smoked had lower levels of a certain gene's activity at birth, which linked to higher levels of liver fat and other health issues later on. This matters because it highlights how maternal smoking can lead to metabolic problems in children, helping us understand the long-term health risks associated with smoking during pregnancy.
Safety and Immunogenicity of Live Viral Vaccines in a Multicenter Cohort of Pediatric Transplant Recipients.
2023
JAMA network open
Feldman AG, Beaty BL, Ferrolino JA, Maron G, Weidner HK +54 more
Plain English This multicenter study examined whether live vaccines for measles, mumps, rubella, and varicella are safe and effective in children who had received solid organ transplants, including 281 recipients from 18 centers. The majority of children developed protective antibody levels after vaccination, most maintained protection at one year, and serious adverse events were rare — with only five mild varicella cases and no graft rejections following vaccination. The results support reconsidering blanket restrictions on live vaccines for selected, stable pediatric transplant recipients.
Living donor liver transplant candidate and donor selection and engagement: Meeting report from the living donor liver transplant consensus conference.
2023
Clinical transplantation
Jesse MT, Jackson WE, Liapakis A, Ganesh S, Humar A +17 more
Plain English Living donor liver transplantation can reduce deaths on the waitlist, but its use in the U.S. remains low. This consensus conference report from the American Society of Transplantation identified barriers to wider adoption and outlined best practices for selecting candidates and engaging potential donors. The goal is to increase access to living donor transplants across more transplant centers.
Advancing the Field of Pediatric Liver Transplantation: Urgent Action Items Identified During the 2022 Society of Pediatric Liver Transplantation Meeting.
2023
Transplantation
Feldman AG, Adams M, Griesemer AD, Horslen S, Kelly B +9 more
Feasibility and Acceptability of a mHealth Self-Management Intervention for Pediatric Transplant Families.
2022
Western journal of nursing research
Lerret SM, Schiffman R, White-Traut R, Medoff-Cooper B, Ahamed SI +14 more
Plain English Researchers studied a mobile health program designed to support families of children who have recently received organ transplants. The program was well-received: 81% of families used the app for at least 24 out of 30 days, and nurses promptly responded to family alerts nearly all the time (99%). These findings suggest that such interventions can provide valuable support during a crucial recovery period, potentially improving family quality of life and health management.
Who this helps: This benefits families of pediatric transplant patients.
Alterations in DNA methylation associate with fatty liver and metabolic abnormalities in a multi-ethnic cohort of pre-teenage children.
2022
Epigenetics
Moylan CA, Mavis AM, Jima D, Maguire R, Bashir M +8 more
Plain English Researchers studied the DNA changes in young children to see if these changes were linked to fatty liver disease, which is becoming more common in kids. They found that out of 90 children aged 7-12, six had non-alcoholic fatty liver disease, mostly among those who were obese. This research is important because identifying these DNA changes early could help target interventions to prevent future health issues related to fatty liver and obesity.
Acceptability of an mHealth Family Self-management Intervention (myFAMI) for Pediatric Transplantation Families: Qualitative Focus.
2022
JMIR nursing
Lerret SM, Flynn E, White-Traut R, Alonso E, Mavis AM +3 more
Plain English Researchers studied a mobile health program called myFAMI, designed to help families manage their child's care after a pediatric organ transplant. The families who used the app during the first 30 days after leaving the hospital found it easy to use and felt it improved their connection with the medical team, leading to better support at home. This is important because improving how families manage care can lead to better health outcomes for transplant patients and could be useful for managing other chronic illnesses.
Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly.
2022
American journal of medical genetics. Part A
Hannah WB, Ryan K, Pendyal S, Burrow TA, Harley SE +5 more
Plain English This study focused on a rare condition called Wolman disease, which can cause an enlarged liver and spleen in infants. Researchers examined a case where a baby with this condition showed significant improvement after starting enzyme replacement therapy, a treatment that has changed the outcomes for children with Wolman disease. The findings highlight the importance of correctly diagnosing this disease early, as it can be confused with other serious conditions, and effective treatment can lead to better health outcomes for affected infants.
Epstein-Barr Virus DNAemia and post-transplant lymphoproliferative disorder in pediatric solid organ transplant recipients.
2022
PloS one
Chang YC, Young RR, Mavis AM, Chambers ET, Kirmani S +4 more
Plain English The study looked at children who had received solid organ transplants and their risk of developing a condition called post-transplant lymphoproliferative disorder (PTLD) linked to the Epstein-Barr virus (EBV). Out of 275 transplant recipients, 14 developed PTLD, and those who had intestinal or multivisceral transplants were at higher risk. High levels of EBV in the blood significantly raised the chance of developing PTLD; for every tenfold increase in EBV levels, the risk of getting PTLD more than doubled. This information is important because it helps identify which pediatric transplant recipients need closer monitoring for potential complications.
Efficacy and safety of mammalian target of rapamycin inhibitors following intestinal and multivisceral transplantation.
2021
Clinical transplantation
Modi K, Segovia M, Mavis A, Schiano T, Patel Y +4 more
Plain English This study looked at the effectiveness and safety of a specific type of medication called mTOR inhibitors in patients who had received intestinal or multi-organ transplants. Out of 22 patients studied, those who started mTOR treatment 24 months after their transplants often experienced improvements in kidney function, with 69% of those needing help for kidney issues showing better results. However, half of the patients stopped taking mTORs due to side effects like swelling and headaches.
Who this helps: This research benefits transplant patients who may struggle with kidney issues after surgery.
Defining Pediatric Failure to Thrive in the Developed World: Validation of a Semi-Objective Diagnosis Tool.
2019
Clinical pediatrics
Larson-Nath C, Mavis A, Duesing L, Van Hoorn M, Walia C +2 more
Plain English Researchers studied a new tool called the Semi-Objective Failure to Thrive (SOFTT) to help diagnose children who are not growing properly, a condition known as failure to thrive (FTT). They tested this tool on 94 children and found it successfully identified FTT, showing that children diagnosed with FTT had significant differences in their growth measurements, such as weight and height (for example, a P-value of less than .0001 for many measurements). This matters because it provides a more reliable way to diagnose FTT, ensuring that affected children receive the help they need.
Who this helps: This helps pediatricians and healthcare providers assess and treat children who may be struggling with growth.
MR Imaging Evaluation of Inflammatory Bowel Disease in Children:: Where Are We Now in 2019.
2019
Magnetic resonance imaging clinics of North America
Schooler GR, Hull NC, Mavis A, Lee EY
Plain English This study looked at how magnetic resonance imaging (MRI) can help evaluate inflammatory bowel disease (IBD) in children. Researchers found that newer MRI techniques have improved the ability to see how severe the disease is, where it is located in the body, and whether there are any complications. This is important because better imaging means doctors can provide more accurate diagnoses and treatment plans for young patients suffering from IBD.
Who this helps: This helps pediatric patients and their doctors manage inflammatory bowel disease more effectively.
Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring.
2019
Genetics in medicine : official journal of the American College of Medical Genetics
Halaby CA, Young SP, Austin S, Stefanescu E, Bali D +7 more
Plain English This study looked at children with glycogen storage disease type III (GSD III) to see how their liver health changes over time. It found that while liver enzyme levels can appear normal as kids grow, many of them actually develop severe liver fibrosis (scarring), especially by the age of 1.25 years, indicating serious long-term liver complications despite dietary treatment. This highlights the importance of regular and thorough monitoring of liver health in these patients, as early signs of liver damage can often go unnoticed.
Cystic biliary atresia: A distinct clinical entity that may mimic choledochal cyst.
2018
Radiology case reports
Schooler GR, Mavis A
Plain English This study looks at cystic biliary atresia (CBA), a rare liver condition in infants that can look like another issue called a choledochal cyst. The researchers found that CBA can be identified through imaging, which shows a cyst in the liver area, but it's crucial to tell the two apart because they need different types of surgery at different times. Proper diagnosis leads to better treatment outcomes for these patients.
Who this helps: This helps infants with biliary atresia and their doctors by ensuring they get the right treatment.
Plain English This study looked at liver transplants (LT) for children with liver cancer, specifically hepatoblastoma (HB) and hepatocellular carcinoma (HCC), over a period from 1987 to 2017. It found that survival rates after these transplants have improved significantly in recent years: the one-year survival rate for HB increased from about 84.6% to 89.1%, and for HCC, it went from about 84.4% to 94.7%. This matters because more children are surviving after transplants, with over 80% living for at least five years, highlighting better treatment outcomes and the need for further research on who can benefit from transplants.
Plain English This paper looks at liver diseases that can affect teenagers, focusing on those with elevated liver enzymes. It highlights several common conditions, like nonalcoholic fatty liver disease and hepatitis, and discusses how to manage these issues effectively. Understanding these diseases is important because they can significantly impact a teenager's health and overall well-being.
Plain English This study looked at how well children with inflammatory bowel disease followed their infliximab treatment at Children's Hospital of Wisconsin. It found that 91.4% of the 151 patients stuck to their treatment plan, and those who did not were more likely to visit the emergency room or be hospitalized. This is important because it highlights that sticking to treatment can lead to better health outcomes for children with this condition.
Vulnerability and chronic illness management in pediatric kidney and liver transplant recipients.
2015
Progress in transplantation (Aliso Viejo, Calif.)
Mavis AM, Ertl A, Chapman S, Cassidy LD, Lerret SM
Plain English This study looked at how children who received kidney or liver transplants and their families adapt to the ongoing challenges of managing their health. It found that higher levels of vulnerability in children were linked to more negative impacts on family life and overall quality of life for both parents and children. Understanding these patterns is important because it highlights the need for better support systems for families dealing with chronic illnesses after organ transplants.
Respiratory syncytial virus and pediatric liver transplant: one center's experience.
2013
Progress in transplantation (Aliso Viejo, Calif.)
Lerret S, Mavis A, Biank V, Telega G
Plain English This study looked at how respiratory syncytial virus (RSV) affects children who have had liver transplants or are waiting for one. The researchers found that two patients died from severe RSV infections, highlighting the virus's serious risks for these vulnerable patients. They recommend giving a preventive medication, palivizumab, to two specific groups: young transplant patients and those with liver disease to help protect them from RSV.
Who this helps: This information benefits pediatric liver transplant patients and their doctors.
Erbaycu AE, Ediboğlu H, Maviş AV, Ozantürk ME, Tuksavul F +2 more
Plain English This study looked at a patient with lung cancer who also developed Fahr's disease, a condition associated with calcium imbalance in the brain. The patient showed signs of movement and speech issues after receiving chemotherapy and radiotherapy. Doctors discovered that the patient had low calcium and hormone levels, likely due to the treatment for lung cancer, which triggered Fahr's disease. This finding is important because it highlights how cancer treatments can lead to new health issues.
Who this helps: This helps patients and doctors by increasing awareness of potential complications from cancer treatments.
Alisha M Mavis Amy G Feldman Shelley Chapman Manal F Abdelmalek Cynthia A Moylan Thomas Schiano Yeh-Chung Chang Rima Fawaz Stacee Lerret Krupa R Mysore
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.